# Documentation Index

## 小分子非临床中文验证模板/NS25318BV01

### NS25318BV01-RAT-BA-REPORT-Final-杨接敏-1@20251226
> Final GLP validation report for the LC-MS/MS quantification of Abaloparatide in SD Rat plasma. Validated range 0.100-50.000 ng/mL. Covers full method validation including selectivity, matrix effect, recovery, and comprehensive stability demonstrating method robustness for PK studies.

- **Document**: [NS25318BV01-RAT-BA-REPORT-Final-杨接敏-1@20251226.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/NS25318BV01-RAT-BA-REPORT-Final-%E6%9D%A8%E6%8E%A5%E6%95%8F-1%4020251226.md)
- **Source**: [小分子非临床中文验证模板/NS25318BV01/NS25318BV01-RAT-BA-REPORT-Final-杨接敏-1@20251226.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/NS25318BV01-RAT-BA-REPORT-Final-%E6%9D%A8%E6%8E%A5%E6%95%8F-1%4020251226.docx)

### NS25318BV01生物分析验证方案(SD rat)_Final@20250901
> Validation Protocol for NS25318BV01 (Abaloparatide in SD Rat Plasma). Outlines the experimental design to validate method NS25318-BA-001 under GLP. Includes plans for assessing system suitability, linearity (0.1-50 ng/mL), accuracy/precision, matrix effects, and various stability conditions (Sep-Nov 2025).

- **Document**: [NS25318BV01生物分析验证方案(SD rat)_Final@20250901.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/NS25318BV01%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%28SD%20rat%29_Final%4020250901.md)
- **Source**: [小分子非临床中文验证模板/NS25318BV01/NS25318BV01生物分析验证方案(SD rat)_Final@20250901.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/NS25318BV01%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%28SD%20rat%29_Final%4020250901.docx)

### Qced NN25318BV01二次数据汇总-LTS(Run7~8)@20251211
> Validated data summary for study NS25318BV01, specifically covering Runs 7-8. Focuses on Long-Term Stability (LTS) data. Includes QCed results for analysis batches used to verify stability of Abaloparatide in SD Rat plasma after established storage periods.

- **Document**: [Qced NN25318BV01二次数据汇总-LTS(Run7~8)@20251211.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/Qced%20NN25318BV01%E4%BA%8C%E6%AC%A1%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB-LTS%28Run7~8%29%4020251211.md)
- **Source**: [小分子非临床中文验证模板/NS25318BV01/Qced NN25318BV01二次数据汇总-LTS(Run7~8)@20251211.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/Qced%20NN25318BV01%E4%BA%8C%E6%AC%A1%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB-LTS%28Run7~8%29%4020251211.xlsx)

### Qced NS25318BV01二次数据汇总-LTS(Run9)@20251217
> Validated data summary for study NS25318BV01, specifically covering Run 9. Focuses on additional Long-Term Stability (LTS) data and stability data extension. Includes QCed results verifying sample integrity after prolonged storage (-70 to -90°C), supporting the method's long-term robustness.

- **Document**: [Qced NS25318BV01二次数据汇总-LTS(Run9)@20251217.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/Qced%20NS25318BV01%E4%BA%8C%E6%AC%A1%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB-LTS%28Run9%29%4020251217.md)
- **Source**: [小分子非临床中文验证模板/NS25318BV01/Qced NS25318BV01二次数据汇总-LTS(Run9)@20251217.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/Qced%20NS25318BV01%E4%BA%8C%E6%AC%A1%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB-LTS%28Run9%29%4020251217.xlsx)

### Qced NS25318BV01二次数据汇总@20250916（1-6）
> QCed data summary for study NS25318BV01, covering Runs 1-6 (Sep 2025). Contains comprehensive initial validation data including System Suitability, Selectivity, Specificity, Matrix Effect, Intra/Inter-batch Accuracy & Precision, Extraction Recovery, and initial Stability assessments (T0, Freeze-thaw).

- **Document**: [Qced NS25318BV01二次数据汇总@20250916（1-6）.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/Qced%20NS25318BV01%E4%BA%8C%E6%AC%A1%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020250916%EF%BC%881-6%EF%BC%89.md)
- **Source**: [小分子非临床中文验证模板/NS25318BV01/Qced NS25318BV01二次数据汇总@20250916（1-6）.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/NS25318BV01/Qced%20NS25318BV01%E4%BA%8C%E6%AC%A1%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020250916%EF%BC%881-6%EF%BC%89.xlsx)


## 小分子非临床中文验证模板/SS25071BV01

### QCed SS25071BV01验证数据汇总-LT@20250914-zr
> Validation data summary for study SS25071BV01 (RESS25071 in Rat Plasma), version 20250914. Includes chemical information, reagents, analysis schedule, system suitability, carryover, regression analysis, back-calculated standards, QC results, and extended stability data including potential long-term stability results.

- **Document**: [QCed SS25071BV01验证数据汇总-LT@20250914-zr.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV01/QCed%20SS25071BV01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB-LT%4020250914-zr.md)
- **Source**: [小分子非临床中文验证模板/SS25071BV01/QCed SS25071BV01验证数据汇总-LT@20250914-zr.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV01/QCed%20SS25071BV01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB-LT%4020250914-zr.xlsx)

### QCed SS25071BV01验证数据汇总@20250617-zr
> Initial validation data summary for study SS25071BV01 (dated 2025-06-17). Covers the initial validation phase including Short-term stability, Accuracy & Precision, Selectivity, and other core validation parameters for RESS25071 in rat plasma, prior to long-term stability completion.

- **Document**: [QCed SS25071BV01验证数据汇总@20250617-zr.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV01/QCed%20SS25071BV01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020250617-zr.md)
- **Source**: [小分子非临床中文验证模板/SS25071BV01/QCed SS25071BV01验证数据汇总@20250617-zr.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV01/QCed%20SS25071BV01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020250617-zr.xlsx)

### SS25071BV01-RAT-BA-REPORT-final-庄蒙@20250929
> Final bioanalytical validation report for study SS25071BV01. Documents the GLP-compliant validation of the LC-MS/MS method for determining RESS25071 (antisense and sense) in SD rat plasma. Includes QA statement, experimental procedures, full validation results, conclusions, and appendices.

- **Document**: [SS25071BV01-RAT-BA-REPORT-final-庄蒙@20250929.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV01/SS25071BV01-RAT-BA-REPORT-final-%E5%BA%84%E8%92%99%4020250929.md)
- **Source**: [小分子非临床中文验证模板/SS25071BV01/SS25071BV01-RAT-BA-REPORT-final-庄蒙@20250929.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV01/SS25071BV01-RAT-BA-REPORT-final-%E5%BA%84%E8%92%99%4020250929.docx)

### SS25071BV01（大鼠）生物分析验证方案@20250515-中文_final
> Final Bioanalytical Validation Protocol for study SS25071BV01. Details the study objectives, schedule, regulatory compliance, materials, and experimental design for validating the LC-MS/MS method (SS25071-BA-001) for RESS25071 in rat plasma, covering all standard validation parameters.

- **Document**: [SS25071BV01（大鼠）生物分析验证方案@20250515-中文_final.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV01/SS25071BV01%EF%BC%88%E5%A4%A7%E9%BC%A0%EF%BC%89%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%4020250515-%E4%B8%AD%E6%96%87_final.md)
- **Source**: [小分子非临床中文验证模板/SS25071BV01/SS25071BV01（大鼠）生物分析验证方案@20250515-中文_final.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV01/SS25071BV01%EF%BC%88%E5%A4%A7%E9%BC%A0%EF%BC%89%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%4020250515-%E4%B8%AD%E6%96%87_final.docx)


## 小分子非临床中文验证模板/SS25071BV02

### QCed SS25071BV02验证数据汇总-LT@20251029
> Validated data summary (Long Term stability version) for study SS25071BV02 (Measurement of FB7013 antisense and sense strands in Cynomolgus Monkey Plasma). Contains comprehensive data tables for the validation of the LC-MS/MS method, including sensitivity, selectivity, specificity, matrix effect, accuracy & precision, recovery, dilution integrity, and extensive stability data (Short-term, Freeze-thaw, Post-preparative, Long-term up to 101/103 days, and Whole blood stability).

- **Document**: [QCed SS25071BV02验证数据汇总-LT@20251029.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV02/QCed%20SS25071BV02%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB-LT%4020251029.md)
- **Source**: [小分子非临床中文验证模板/SS25071BV02/QCed SS25071BV02验证数据汇总-LT@20251029.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV02/QCed%20SS25071BV02%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB-LT%4020251029.xlsx)

### QCed SS25071BV02验证数据汇总@20250612
> Validated data summary for study SS25071BV02 (dated 2025-06-12). Contains initial validation data covering Analysis Schedule (batches 1-5), Selectivity, Specificity, Matrix Effect, Accuracy & Precision, Recovery, and initial Stability assessments for FB7013 in Cynomolgus Monkey plasma.

- **Document**: [QCed SS25071BV02验证数据汇总@20250612.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV02/QCed%20SS25071BV02%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020250612.md)
- **Source**: [小分子非临床中文验证模板/SS25071BV02/QCed SS25071BV02验证数据汇总@20250612.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV02/QCed%20SS25071BV02%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020250612.xlsx)

### SS25071BV02-RAT-BA-REPORT-Final-庄蒙@20251117
> Final bioanalytical validation report for study SS25071BV02. Documents the validation of an LC-MS/MS method for determining FB7013 (free form, antisense and sense strands) in Cynomolgus Monkey EDTA-K2 plasma. Key contents include GLP compliance, study details, materials, method SS25071-BA-002, and validation results for all parameters (selectivity, specificity, linearity, A&P, recovery, stability, etc.).

- **Document**: [SS25071BV02-RAT-BA-REPORT-Final-庄蒙@20251117.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV02/SS25071BV02-RAT-BA-REPORT-Final-%E5%BA%84%E8%92%99%4020251117.md)
- **Source**: [小分子非临床中文验证模板/SS25071BV02/SS25071BV02-RAT-BA-REPORT-Final-庄蒙@20251117.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV02/SS25071BV02-RAT-BA-REPORT-Final-%E5%BA%84%E8%92%99%4020251117.docx)

### SS25071BV02（食蟹猴）生物分析验证方案@20250520-中文_final
> Final Bioanalytical Validation Protocol for study SS25071BV02. Outlines the plan to validate the LC-MS/MS method for FB7013 (antisense and sense strands) in Cynomolgus Monkey EDTA-K2 plasma. Includes study objectives, schedule (May-Oct 2025), compliance (NMPA, FDA, OECD), materials, and experimental design for full method validation including system suitability, carryover, selectivity, specificity, matrix effect, linearity, accuracy & precision, recovery, dilution integrity, and stability.

- **Document**: [SS25071BV02（食蟹猴）生物分析验证方案@20250520-中文_final.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV02/SS25071BV02%EF%BC%88%E9%A3%9F%E8%9F%B9%E7%8C%B4%EF%BC%89%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%4020250520-%E4%B8%AD%E6%96%87_final.md)
- **Source**: [小分子非临床中文验证模板/SS25071BV02/SS25071BV02（食蟹猴）生物分析验证方案@20250520-中文_final.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25071BV02/SS25071BV02%EF%BC%88%E9%A3%9F%E8%9F%B9%E7%8C%B4%EF%BC%89%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%4020250520-%E4%B8%AD%E6%96%87_final.docx)


## 小分子非临床中文验证模板/SS25255BV01

### QCed SS25255BV01验证数据汇总@20251031-中文
> Validated data summary for study SS25255BV01 (dated 2025-10-31). Contains initial stability data for free Dxd in rat plasma, focusing on short-term, freeze-thaw, post-preparative, and whole blood stability in the presence of the co-administered drug.

- **Document**: [QCed SS25255BV01验证数据汇总@20251031-中文.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255BV01/QCed%20SS25255BV01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020251031-%E4%B8%AD%E6%96%87.md)
- **Source**: [小分子非临床中文验证模板/SS25255BV01/QCed SS25255BV01验证数据汇总@20251031-中文.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255BV01/QCed%20SS25255BV01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020251031-%E4%B8%AD%E6%96%87.xlsx)

### QCed SS25255BV01验证数据汇总@20251207 LT-zr
> Validated data summary (Long Term stability version) for study SS25255BV01. Includes comprehensive data tables for free Dxd in rat plasma: method overview, standard curves, QC results, and extended stability data including long-term stability (up to 108 days) in the presence of the co-administered drug.

- **Document**: [QCed SS25255BV01验证数据汇总@20251207 LT-zr.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255BV01/QCed%20SS25255BV01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020251207%20LT-zr.md)
- **Source**: [小分子非临床中文验证模板/SS25255BV01/QCed SS25255BV01验证数据汇总@20251207 LT-zr.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255BV01/QCed%20SS25255BV01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020251207%20LT-zr.xlsx)

### SS25255BV01(Rat_Dxd_free)生物分析验证方案@20250818-Final
> Validation protocol for study SS25255BV01. This is a partial validation plan for the LC-MS/MS method (SS24160-BA-002) to determine free Dxd in SD rat EDTA-K2 plasma. The primary objective is to validate the stability of free Dxd in the presence of "Potential Drug A" to support non-clinical co-administration studies.

- **Document**: [SS25255BV01(Rat_Dxd_free)生物分析验证方案@20250818-Final.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255BV01/SS25255BV01%28Rat_Dxd_free%29%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%4020250818-Final.md)
- **Source**: [小分子非临床中文验证模板/SS25255BV01/SS25255BV01(Rat_Dxd_free)生物分析验证方案@20250818-Final.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255BV01/SS25255BV01%28Rat_Dxd_free%29%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%4020250818-Final.docx)

### SS25255BV01-Rat_Dxd_free-BA-REPORT-final-钱哲元@20251226
> Final bioanalytical validation report for study SS25255BV01. Validates the partial LC-MS/MS method for free Dxd in SD rat plasma. Identifies detailed stability assessments (short-term, freeze-thaw, long-term) of free Dxd in the presence of the co-administered "Potential Drug A", confirming method reliability for specific study conditions.

- **Document**: [SS25255BV01-Rat_Dxd_free-BA-REPORT-final-钱哲元@20251226.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255BV01/SS25255BV01-Rat_Dxd_free-BA-REPORT-final-%E9%92%B1%E5%93%B2%E5%85%83%4020251226.md)
- **Source**: [小分子非临床中文验证模板/SS25255BV01/SS25255BV01-Rat_Dxd_free-BA-REPORT-final-钱哲元@20251226.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255BV01/SS25255BV01-Rat_Dxd_free-BA-REPORT-final-%E9%92%B1%E5%93%B2%E5%85%83%4020251226.docx)


## 小分子非临床中文验证模板/SS25255NM01

### QCed SS25255NM01验证数据汇总@20251201-zr
> Validated data summary for study SS25255NM01. Contains data for the partial validation of an LC-MS/MS method for free Dxd and free T785 (QHL-1031 Payload) in BALB/c nude mouse plasma. Includes System Suitability, Carryover, Regression parameters, Standard Curve back-calculations, Inter/Intra-batch Precision & Accuracy (LQC, GMQC, MQC, HQC), and Short-term stability (16h).

- **Document**: [QCed SS25255NM01验证数据汇总@20251201-zr.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255NM01/QCed%20SS25255NM01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020251201-zr.md)
- **Source**: [小分子非临床中文验证模板/SS25255NM01/QCed SS25255NM01验证数据汇总@20251201-zr.xlsx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255NM01/QCed%20SS25255NM01%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020251201-zr.xlsx)

### SS25255NM01(Mouse)生物分析验证方案@20251110
> Partial Bioanalytical Validation Protocol for study SS25255NM01. Detailing the plan to validate method SS25255-BA-003 for the quantification of free Dxd and free T785 (QHL-1031 Payload) in BALB/c nude mouse plasma. Covers objectives, materials, and experimental designs for System Suitability, Carryover, Standard Curve range (1.5-1500 pmol/mL), Intra-batch A&P, and Short-term stability.

- **Document**: [SS25255NM01(Mouse)生物分析验证方案@20251110.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255NM01/SS25255NM01%28Mouse%29%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%4020251110.md)
- **Source**: [小分子非临床中文验证模板/SS25255NM01/SS25255NM01(Mouse)生物分析验证方案@20251110.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255NM01/SS25255NM01%28Mouse%29%E7%94%9F%E7%89%A9%E5%88%86%E6%9E%90%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88%4020251110.docx)

### SS25255NM01-Mouse Plasma-BA-REPORT-final-钱哲元@20251226
> Final Bioanalytical Validation Report for study SS25255NM01. Documents the partial validation results of the LC-MS/MS method for free Dxd and free T785 (QHL-1031 Payload) in BALB/c nude mouse plasma. Confirms successful validation of parameters: System Suitability, Carryover, Linearity (1.5-1500 pmol/mL), Intra-batch Precision & Accuracy, and Short-term Stability (16h in ice-water bath).

- **Document**: [SS25255NM01-Mouse Plasma-BA-REPORT-final-钱哲元@20251226.md](markdown_docs/%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255NM01/SS25255NM01-Mouse%20Plasma-BA-REPORT-final-%E9%92%B1%E5%93%B2%E5%85%83%4020251226.md)
- **Source**: [小分子非临床中文验证模板/SS25255NM01/SS25255NM01-Mouse Plasma-BA-REPORT-final-钱哲元@20251226.docx](%E5%B0%8F%E5%88%86%E5%AD%90%E9%9D%9E%E4%B8%B4%E5%BA%8A%E4%B8%AD%E6%96%87%E9%AA%8C%E8%AF%81%E6%A8%A1%E6%9D%BF/SS25255NM01/SS25255NM01-Mouse%20Plasma-BA-REPORT-final-%E9%92%B1%E5%93%B2%E5%85%83%4020251226.docx)


## 益诺思脱敏的报告和方案_SS24050BV01

### 二次数据QCed SS24050BV01-验证数据汇总@20240628
> Validated data summary for study SS24050BV01 (810Z00-T in Pig Plasma). Includes detailed tables for method overview (LC-MS/MS), reference standards, reagents, analysis schedule (Mar-Jun 2024), system suitability, carryover, selectivity, calibration curves (50-25000 pg/mL), QC data, recovery, dilution integrity, and stability test results (short-term, freeze-thaw, long-term).

- **Document**: [二次数据QCed SS24050BV01-验证数据汇总@20240628.md](markdown_docs/%E7%9B%8A%E8%AF%BA%E6%80%9D%E8%84%B1%E6%95%8F%E7%9A%84%E6%8A%A5%E5%91%8A%E5%92%8C%E6%96%B9%E6%A1%88_SS24050BV01/%E4%BA%8C%E6%AC%A1%E6%95%B0%E6%8D%AEQCed%20SS24050BV01-%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020240628.md)
- **Source**: [益诺思脱敏的报告和方案_SS24050BV01/二次数据QCed SS24050BV01-验证数据汇总@20240628.xlsx](%E7%9B%8A%E8%AF%BA%E6%80%9D%E8%84%B1%E6%95%8F%E7%9A%84%E6%8A%A5%E5%91%8A%E5%92%8C%E6%96%B9%E6%A1%88_SS24050BV01/%E4%BA%8C%E6%AC%A1%E6%95%B0%E6%8D%AEQCed%20SS24050BV01-%E9%AA%8C%E8%AF%81%E6%95%B0%E6%8D%AE%E6%B1%87%E6%80%BB%4020240628.xlsx)

### 报告SS24050BV01-Pig-BA-REPORT-Final-QYX@20240627
> Final bioanalytical validation report for study SS24050BV01. Validates the LC-MS/MS method for determining 810Z00-T in Bama Minipig EDTA-K2 plasma. Confirms the method meets GLP requirements with a linear range of 50.000~25000.000 pg/mL. Covers all validation parameters including accuracy, precision, selectivity, recovery, and comprehensive stability.

- **Document**: [报告SS24050BV01-Pig-BA-REPORT-Final-QYX@20240627.md](markdown_docs/%E7%9B%8A%E8%AF%BA%E6%80%9D%E8%84%B1%E6%95%8F%E7%9A%84%E6%8A%A5%E5%91%8A%E5%92%8C%E6%96%B9%E6%A1%88_SS24050BV01/%E6%8A%A5%E5%91%8ASS24050BV01-Pig-BA-REPORT-Final-QYX%4020240627.md)
- **Source**: [益诺思脱敏的报告和方案_SS24050BV01/报告SS24050BV01-Pig-BA-REPORT-Final-QYX@20240627.docx](%E7%9B%8A%E8%AF%BA%E6%80%9D%E8%84%B1%E6%95%8F%E7%9A%84%E6%8A%A5%E5%91%8A%E5%92%8C%E6%96%B9%E6%A1%88_SS24050BV01/%E6%8A%A5%E5%91%8ASS24050BV01-Pig-BA-REPORT-Final-QYX%4020240627.docx)

### 验证方案SS24050BV01
> Validation protocol for study SS24050BV01. Outlines the plan to validate the LC-MS/MS method (SS24050-BA-001) for quantifying 810Z00-T in Pig EDTA-K2 plasma. Specifies experimental designs, acceptance criteria, and procedures for evaluating system suitability, linearity, accuracy, precision, recovery, selectivity, matrix effect, dilution integrity, and stability.

- **Document**: [验证方案SS24050BV01.md](markdown_docs/%E7%9B%8A%E8%AF%BA%E6%80%9D%E8%84%B1%E6%95%8F%E7%9A%84%E6%8A%A5%E5%91%8A%E5%92%8C%E6%96%B9%E6%A1%88_SS24050BV01/%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88SS24050BV01.md)
- **Source**: [益诺思脱敏的报告和方案_SS24050BV01/验证方案SS24050BV01.docx](%E7%9B%8A%E8%AF%BA%E6%80%9D%E8%84%B1%E6%95%8F%E7%9A%84%E6%8A%A5%E5%91%8A%E5%92%8C%E6%96%B9%E6%A1%88_SS24050BV01/%E9%AA%8C%E8%AF%81%E6%96%B9%E6%A1%88SS24050BV01.docx)


